Litcius/Paper detail

Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye

Gou Young Koh, Hellmut G. Augustin, Peter A. Campochiaro

2022Trends in Molecular Medicine11 citationsDOI

Topics & Concepts

Macular degenerationAngiopoietin receptorVascular endothelial growth factorMedicineAngiopoietinVEGF receptorsVascular endothelial growth factor AAngiopoietin 2AngiogenesisAntibodyOphthalmologyImmunologyCancer researchRetinal Diseases and TreatmentsAngiogenesis and VEGF in CancerComplement system in diseases
Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye | Litcius